Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Miguel Á. Sosa-Velázquez"'
Autor:
Patricia Gómez-Rosas, Miguel Á. Sosa-Velázquez, Lesly A. Yáñez-Funes, José J. González-Trejo, Karim Majluf-Cruz, Irma Isordia-Salas, Gregorio Ignacio-Ibarra, Martín Almaraz-Delgado, Luis A. Moreno-Ruiz, Jesús S. Valencia-Chávez, Jesús Hernández-Juárez, David Vázquez-Rubiel, Víctor Domínguez-Reyes, Rodrigo Arreola-Díaz, Ma. Teresa García-Lee, Jorge Vela-Ojeda, Abraham Majluf-Cruz
Publikováno v:
Gaceta Médica de México, Vol 157, Iss 3 (2021)
Externí odkaz:
https://doaj.org/article/3b03193522cc4f9fa6e7c2bd8e556316
Autor:
Víctor Domínguez-Reyes, David Vázquez-Rubiel, Abraham Majluf-Cruz, Miguel Á. Sosa-Velázquez, Rodrigo Arreola-Diaz, Lesly A. Yáñez-Funes, Jesús Hernández-Juárez, Irma Isordia-Salas, Ma. Teresa García-Lee, Martín Almaraz-Delgado, Gregorio Ignacio-Ibarra, Jesús S. Valencia-Chávez, Karim Majluf-Cruz, Luis Antonio Moreno-Ruiz, Jorge Vela-Ojeda, José J. González-Trejo, Patricia Gomez-Rosas
Publikováno v:
Gaceta Médica de México, Vol 157, Iss 3 (2021)
Vitamin K antagonists (VKA) are a therapeutic alternative in patients with venous thromboembolic disease; however, numerous factors affect their pharmacology.To evaluate the quality of VKA anticoagulation at three different time periods in Mexico.Pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::271b75b3290740be58524f9bd17976c0
https://www.gacetamedicademexico.com/frame_esp.php?id=593
https://www.gacetamedicademexico.com/frame_esp.php?id=593